Use of IL-12 in hematopoiesis

• 收藏
• 分享

专利权人:

ユニバーシティ オブ サザン カリフォルニア

发明人:

アンダーソン、ダブリュ．・フレンチ,ジャオ、イ,チェン、ティンチャオ,アンダーソン、ダブリュ.・フレンチ

申请号：

JP2006517858

公开号：

JP5517394B2

申请日:

2004.07.06

申请国别(地区):

JP

年份:

2014

代理人:

摘要：

Embodiments of the present invention are directed to uses of Interleukin-12 (IL­12) in enhancing or stimulating hematopoietis to yield hematopoietic recovery in a mammal in need. Particular embodiments of the invention are directed to uses of IL-12 as an adjuvant therapy to alleviate the hematopoietic toxicities associated with one or more treatment regimens used to combat a disease state. Other embodiments include uses of IL-12 to ameliorate various hematopoietic deficiencies. Still other embodiments are directed to uses of IL-12 for in-vivo proliferation of hematopoietic repopulating cells, hematopoietic progenitor cells and hematopoietic stem cells. Other disclosed embodiments are directed to uses of I1-12 for bone marrow preservation or recovery.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/